Current position:Home >Product >
Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]
Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl](245329-79-7)
- Name: Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]
- Synonyms:Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]
- Molecular Formula:C32H54 N2 O4
- Molecular Weight:530.78
- CAS Registry Number:245329-79-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.245329-79-7 N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-hexadecanamide
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 245520-69-8/N3-CYCLOPROPYL-7-[[4-(1-METHYLETHYL)PHENYL]METHYL]-7H-PYRROLO[3,2-F]QUINAZOLINE-1,3-DIAMINE DIHYDROCHLORIDE
- 245519-30-6/QUATERNIUM-78
- 245514-32-3/N-[4-[2-[(3aS,9bR)-8-Cyano-1,2,3,3a,4,9b-hexahydro[1]benzopyrano[3,4-c]pyrrol-2-yl]ethyl]phenyl]acetamide
- 245503-15-5/2-Oxazolemethanol,4,5-dihydro-alpha,alpha-dimethyl-4-(1-methylethyl)-,(4R)-(9CI)
- 245467-35-0/1H-Pyrazole-5-carboxylicacid,3-(acetylamino)-1-methyl-,methylester(9CI)
- 245450-02-6/4-(1H-Pyrazolo[3,4-d]pyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester
- 245447-88-5/1H-Azirino[2,3-a]indolizine(9CI)
- 34489-85-5/2-AMINO-N-(2-BROMOPHENYL)BENZAMIDE
- 245443-51-0/COAGULATION FACTOR II RECEPTOR-LIKE 3 (1-6) AMIDE (HUMAN) TRIFLUOROACETATE
- 245430-28-8/(R)-(+)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-1,2,3-DINAPHTHO(D12,F12)DIOXAPHOSPHINE
- 245429-73-6/2-Azabicyclo[2.2.1]heptane-3-carboxylicacid,ethylester,(1R,3R,4S)-rel-(9CI)
- 245413-62-1/3-Pyridinecarboxylicacid,6-[[(dimethylamino)methylene]amino]-,methylester(9CI)
- 34488-27-2/1,3-Thiazepine-6-carboxylicacid,2-amino-4,5,6,7-tetrahydro-4-oxo-(9CI)
- 245368-86-9/Butanoic acid, 2-amino-4-nitro-, methyl ester (9CI)
- 245365-64-4/N-CARBOBENZOXY-2-NITROBENZENESULFONAMIDE
- 245343-67-3/2H-1,4-Oxazin-2-one,3,6-dihydro-3,5,6,6-tetramethyl-(9CI)
- 245332-22-3/L-Isoleucine, 5-methoxy- (9CI)
- 245329-88-8/Hexadecanamide, N-[(1R,2R)-2-(4-chlorophenyl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-
- 245329-80-0/Hexadecanamide, N-[(1R,2R)-2-(1,3-benzodioxol-5-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-
- 245329-79-7/Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]
- 245329-77-5/Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-(1-pyrrolidinylmethyl)ethyl]-
- 245325-34-2/1H-Pyrazolo[3,4-c]pyridine-3-carbonitrile(9CI)
- 245321-46-4/2-Pyrimidinecarbonitrile, 4-amino- (9CI)
- 245320-85-8/Ethanone, 1-(1R,2R,5R,6S)-9-oxatricyclo[4.2.1.02,5]non-7-en-2-yl-, rel- (9CI)
- 245128-91-0/2-amino-6-oxo-hexa-2,4-dienoic acid
- 245124-18-9/2,5-Furandione, 3-(hydroxymethyl)-4-methyl- (9CI)
- 245116-17-0/3-CHLORO-5-HYDROXY-BENZOIC ACID BENZYL ESTER
- 245114-99-2/GALANIN-LIKE PEPTIDE (HUMAN)
- 245114-97-0/GALANIN-LIKE PEPTIDE (RAT)
- 245111-17-5/erythro-Pent-1-enitol, 3,4-anhydro-1,2,5-trideoxy-5-[[(1,1-